BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11341541)

  • 1. Man-made respirable-sized organic fibers: what do we know about their toxicological profiles?
    Warheit DB; Reed KL; Webb TR
    Ind Health; 2001 Apr; 39(2):119-25. PubMed ID: 11341541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung proliferative and clearance responses to inhaled para-aramid RFP in exposed hamsters and rats: comparisons with chrysotile asbestos fibers.
    Warheit DB; Snajdr SI; Hartsky MA; Frame SR
    Environ Health Perspect; 1997 Sep; 105 Suppl 5(Suppl 5):1219-22. PubMed ID: 9400727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential pulmonary effects of man-made organic fiber (MMOF) dusts.
    Warheit DB; Hart GA; Hesterberg TW; Collins JJ; Dyer WM; Swaen GM; Castranova V; Soiefer AI; Kennedy GL
    Crit Rev Toxicol; 2001 Nov; 31(6):697-736. PubMed ID: 11763480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradability of inhaled para-aramid respirable-sized fiber-shaped particulates: mechanistic in vivo and in vitro studies.
    Warheit DB; Hartsky MA; Reed KL; Webb TR
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):78-88. PubMed ID: 11437651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradability of para-aramid respirable-sized fiber-shaped particulates (RFP) in human lung cells.
    Warheit DB; Reed KL; Stonehuerner JD; Ghio AJ; Webb TR
    Toxicol Sci; 2006 Jan; 89(1):296-303. PubMed ID: 16237190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradability of inhaled p-aramid respirable fiber-shaped particulates (RFP): mechanisms of RFP shortening and evidence of reversibility of pulmonary lesions.
    Warheit DB; Reed KL; Pinkerton KE; Webb TR
    Toxicol Lett; 2002 Feb; 127(1-3):259-67. PubMed ID: 12052666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradability of inhaled p-aramid respirable fibre-shaped particulates: representative of other synthetic organic fibre-types?
    Warheit DB; Hartsky MA; Webb TR
    Int Arch Occup Environ Health; 2000 Jun; 73 Suppl():S75-8. PubMed ID: 10968565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary effects in rats inhaling size-separated chrysotile asbestos fibres or p-aramid fibrils: differences in cellular proliferative responses.
    Warheit DB; Hartsky MA; Frame SR
    Toxicol Lett; 1996 Nov; 88(1-3):287-92. PubMed ID: 8920750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the clearance of respirable para-aramid, chrysotile and glass fibres from rat lungs.
    Searl A
    Ann Occup Hyg; 1997 Apr; 41(2):217-33. PubMed ID: 9155241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhalation toxicology of p-aramid fibrils.
    Donaldson K
    Crit Rev Toxicol; 2009; 39(6):487-500. PubMed ID: 19545198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hazards of chrysotile asbestos and its substitutes: A European perspective.
    Harrison PT; Levy LS; Patrick G; Pigott GH; Smith LL
    Environ Health Perspect; 1999 Aug; 107(8):607-11. PubMed ID: 10417355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung injury and expression of p53 and p16 in Wistar rats induced by respirable chrysotile fiber dust from four primary areas of China.
    Zeng Y; Cui Y; Ma J; Huo T; Dong F; Zhang Q; Deng J; Zhang X; Yang J; Wang Y
    Environ Sci Pollut Res Int; 2018 Aug; 25(23):22389-22399. PubMed ID: 28963651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chamber for testing asbestos-containing products: validation and testing of a re-created chrysotile-containing joint compound.
    Sheehan PJ; Brorby GP; Berman DW; Bogen KT; Holm SE
    Ann Occup Hyg; 2011 Aug; 55(7):797-809. PubMed ID: 21795244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Risks of Cancer from Drywall Finishing Based on Stochastic Modeling of Cumulative Exposures to Respirable Dusts and Chrysotile Asbestos Fibers.
    Boelter FW; Xia Y; Dell L
    Risk Anal; 2015 May; 35(5):859-71. PubMed ID: 25428276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalation tolerance study for p-aramid respirable fiber-shaped particulates (RFP) in rats.
    Bellmann B; Creutzenberg O; Dasenbrock C; Ernst H; Pohlmann G; Muhle H
    Toxicol Sci; 2000 Mar; 54(1):237-50. PubMed ID: 10746951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the pathogenicity of man-made vitreous fibers (MMVF).
    Oberdörster G
    Int Arch Occup Environ Health; 2000 Jun; 73 Suppl():S60-8. PubMed ID: 10968563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats.
    Hesterberg TW; Hart GA; Chevalier J; Miiller WC; Hamilton RD; Bauer J; Thevenaz P
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):68-82. PubMed ID: 9875301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemical and physical characteristics and toxicology of man-made mineral fibers].
    Foà V; Basilico S
    Med Lav; 1999; 90(1):10-52. PubMed ID: 10339953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition, clearance, and shortening of Kevlar para-aramid fibrils in acute, subchronic, and chronic inhalation studies in rats.
    Kelly DP; Merriman EA; Kennedy GL; Lee KP
    Fundam Appl Toxicol; 1993 Oct; 21(3):345-54. PubMed ID: 8258388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.